LifeStance Health Group, Inc. Common Stock (LFST) is a publicly traded Healthcare sector company. As of May 21, 2026, LFST trades at $7.68 with a market cap of $2.98B and a P/E ratio of 0.00. LFST moved -0.71% today. Year to date, LFST is +8.94%; over the trailing twelve months it is +31.73%. Its 52-week range spans $3.74 to $8.89. Analyst consensus is strong buy with an average price target of $10.11. Rallies surfaces LFST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LifeStance Health Prices 35M-Share Offering at $8.15, Plans 6M-Share Repurchase: LifeStance Health Group priced a secondary offering of 35 million shares at $8.15 each, with all proceeds to selling stockholders and no proceeds to the company. The company agreed to repurchase 6 million shares from the underwriter at the same price, subject to customary closing conditions.
| Metric | Value |
|---|---|
| Price | $7.68 |
| Market Cap | $2.98B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.89 |
| 52-Week Low | $3.74 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.49B |
| Net Income | $23.20M |
| Gross Margin | 0.00% |
9 analysts cover LFST: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.11.